Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: osteoporosis

Rheumatology Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  January 1, 2013

Information on new approvals and medication safety rheumatologists need to know

Filed under:Drug Updates Tagged with:adalimumabDrugsFDAguidelineSafety

Welcome New ACR and ARHP Leaders

Staff  |  December 1, 2012

The American College of Rheumatology (ACR) welcomes the newest members of the ACR board of directors and the Association of Rheumatology Health Professionals (ARHP) executive committee

Filed under:From the CollegeProfessional TopicsProfilesResearch Rheum Tagged with:AC&RACR Board of DirectorsACR/ARHP Annual MeetingAmerican College of Rheumatology (ACR)EducationProfileResearch

Coding Corner Question: November

Staff  |  November 1, 2012

Test your knowledge of the level of medical decision making (MDM) for an evaluation and management (E/M) office visit of a patient whose rheumatoid arthritis is worse on chronic medicine, whose osteoporosis is stable on chronic medicine, and who presents with a new problem of elevated blood pressure (BP)

Filed under:Billing/CodingConditionsOsteoarthritis and Bone DisordersPractice Support Tagged with:BillingCodingE&MEvaluation and ManagementimagingOsteoporosisPractice ManagementRheumatoid arthritisrheumatologist

Coding Corner Answer: November Coding Challenge

Staff  |  November 1, 2012

Coding for medical decision making in the evaluation and management (E/M) for assessment and treatment of rheumatoid arthritis, osteoporosis, and elevated blood pressure

Filed under:Billing/CodingPractice Support Tagged with:BillingCodingE&MEvaluation and ManagementimaginglabsPractice Managementrheumatologist

Healthcare Professionals Find Benefits in Specialized Rheumatology Training Course

Ann Kepler  |  November 1, 2012

Enhanced caregiver-patient interactions, patient evaluations, patient education, and practice productivity are considered positive outcomes of the American College of Rheumatology’s (ACR) Advanced Rheumatology Course (ARC)

Filed under:Career DevelopmentEducation & TrainingProfessional Topics Tagged with:AC&RAmerican College of Rheumatology (ACR)EducationrheumatologistTraining

Drug Updates: Lorcaserin, Acetaminophen, and More

Michele B. Kaufman, PharmD, BCGP  |  September 5, 2012

information on new approvals and medication safety

Filed under:Axial SpondyloarthritisBiologics/DMARDsConditionsDrug UpdatesPsoriatic ArthritisRheumatoid Arthritis Tagged with:acetaminophenAnkylosing SpondylitisApprovalsBiologicsdrugFDAPipelinePsoriatic ArthritisrituximabSafetySteroids

Rheumatology Clinical Registry Integrates AIM:RA

Staff  |  July 9, 2012

AIM:RA is a web-based self-evaluation of practice performance tool designed to guide a physician through medical-chart data abstraction using a series of questions related directly to evidence-based quality indicators.

Filed under:Career DevelopmentCertificationConditionsFrom the CollegeInformation TechnologyPractice SupportProfessional TopicsQuality Assurance/ImprovementRheumatoid ArthritisTechnologyTechnology Tagged with:AC&RAmerican College of Rheumatology (ACR)CertificationMedicareMOCpractice performancequality improvementRheumatoid arthritisrheumatologistTechnology

California Rheumatologists Explore Managed Care, Treatment Options

Larry Beresford  |  July 9, 2012

Advances in SLE, osteoporosis, and RA highlighted at California Rheumatology Alliance meeting.

Filed under:Career DevelopmentConditionsEducation & TrainingLegislation & AdvocacyOsteoarthritis and Bone DisordersProfessional TopicsResearch Rheum Tagged with:ACAAffordable Care Act (ACA)BiologicsdrugHealthcare ReformLegislationLupusmanaged careMedicareOsteoporosispatient careradiographResearchRheumatoid arthritisrheumatologistSystemic lupus erythematosus

Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  July 9, 2012

Information on new approvals and medication safety.

Filed under:AnalgesicsAxial SpondyloarthritisBiologics/DMARDsConditionsDrug UpdatesRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:Ankylosing SpondylitisBiologicsbiophosphonatesdrugJAK inhibitorsjanus kinaseMethotrexateopioidPainRheumatoid arthritisrheumatologistrituximabSafetySystemic lupus erythematosustocilizumabTofacitinib

Medication Quick Guides Offer Infusion Staff a Streamlined Resource

Susan Richmond, MS, PA-C; Karla B. Jones, RN, MS, CPNP  |  June 10, 2012

The ACR/ARHP Medication Quick Guides offer easily accessable pharmaceutical information to rheumatologists.

Filed under:Biologics/DMARDsDrug UpdatesFrom the College Tagged with:AC&RAmerican College of Rheumatology (ACR)Association of Rheumatology Professionals (ARP)BiologicsdrugpharmacyresourceSafety

  • « Previous Page
  • 1
  • …
  • 42
  • 43
  • 44
  • 45
  • 46
  • …
  • 58
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences